Lotus Pharm Co Ltd Company Profile
What is the competitive landscape for LOTUS PHARM CO LTD
LOTUS PHARM CO LTD has six approved drugs.
There is one tentative approval on LOTUS PHARM CO LTD drugs.
Drugs and US Patents for Lotus Pharm Co Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lotus Pharm Co Ltd | LEVONORGESTREL | levonorgestrel | TABLET;ORAL | 202684-001 | Sep 2, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Lotus Pharm Co Ltd | METHOTREXATE SODIUM | methotrexate sodium | TABLET;ORAL | 209787-001 | Apr 23, 2021 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Lotus Pharm Co Ltd | LEVETIRACETAM | levetiracetam | TABLET;ORAL | 090906-003 | Oct 31, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

